MEDIFAST INC (MED)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $226k
- Sep 29 · Routine
- Form 4 sales
- 97
- On record
- Form 144 notices
- 4
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Sep 29, 2026Routine
Chard Daniel R, Director, sold 12.8% of their holdings
$226k19,089 shares at $11.86
- Sep 29, 2026Notice
Chard Daniel R, Director, filed a notice to sell 9,544 shares
$112k9,544 shares
- Sep 28, 2026Notice
Chard Daniel R, Director, filed a notice to sell 9,545 shares
$114k9,545 shares
- Mar 8, 2024Unusual
Schlackman Scott, Director, sold 34.2% of their holdings
$160k4,053 shares at $39.44
- Mar 8, 2024Notice
Schlackman Scott, Director, filed a notice to sell 4,053 shares
$160k4,053 shares
- Oct 6, 2023Unusual
Hallquist Constance J., Other, sold 72.3% of their holdings
$415k5,613 shares at $73.87
- Aug 15, 2023Unusual
Brown Jeffrey J, Director, sold 100% of their holdings
$3.5M38,316 shares at $91.14
- Aug 14, 2023Notice
Brown Jeffrey J, Director, filed a notice to sell 38,316 shares
$3.6M38,316 shares
- Mar 10, 2023Plan not stated
Schlackman Scott, Director, sold 23.2% of their holdings
$239k2,200 shares at $108.68
- Mar 10, 2022Unusual
Thomas Andrea B, Director, sold 41.2% of their holdings
$200k1,150 shares at $174.31
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2026 | Nov 20, 2026 | MED | Kiai Parsa | Director | Bought | 94,036 | $12.06 | $1.1M | 23,795 | SEC |
| Nov 4, 2026 | Nov 6, 2026 | MED | Kiai Parsa | Director | Bought | 661 | $13.03 | $9k | 21,089 | SEC |
| Oct 28, 2026 | Oct 30, 2026 | MED | Kiai Parsa | Director | Bought | 5,557 | $12.24 | $68k | 20,428 | SEC |
| Sep 29, 2026 | Sep 30, 2026 | MED | Chard Daniel R | Director | Sold | 19,089 | $11.86 | $226k | 130,609 | SEC |
| Aug 26, 2026 | Aug 28, 2026 | MED | Kiai Parsa | Director | Bought | 43,150 | $12.26 | $529k | 20,270 | SEC |
| Aug 24, 2026 | Aug 26, 2026 | MED | Kiai Parsa | Director | Bought | 4,329 | $12.00 | $52k | 19,095 | SEC |
| Aug 20, 2026 | Aug 21, 2026 | MED | Kiai Parsa | Director | Bought | 72,487 | $11.62 | $843k | 18,977 | SEC |
| May 26, 2026 | May 28, 2026 | MED | Rose Jeffrey Matthew | Director | Awarded | 18,419 | 18,419 | SEC | ||
| May 26, 2026 | May 28, 2026 | MED | Kiai Parsa | Director | Awarded | 19,317 | 19,317 | SEC | ||
| May 26, 2026 | May 28, 2026 | MED | Thomas Andrea B | Director | Awarded | 11,680 | 35,697 | SEC | ||
| May 26, 2026 | May 28, 2026 | MED | Schlackman Scott | Director | Awarded | 11,680 | 42,229 | SEC | ||
| May 26, 2026 | May 28, 2026 | MED | Geary Elizabeth A. | Director | Awarded | 11,680 | 31,225 | SEC | ||
| May 26, 2026 | May 28, 2026 | MED | Xian Ming | Director | AwardedRestricted Stock Units (cash settled) | 11,680 | 43,823 | SEC | ||
| May 11, 2026 | May 12, 2026 | MED | Schlackman Scott | Director | Bought | 5,000 | $12.59 | $63k | 30,549 | SEC |
| Mar 25, 2026 | Mar 27, 2026 | MED | MacKenzie Jonathan Barrett | VP, Finance & CAO | Withheld for tax | 1,130 | $9.62 | $11k | 10,008 | SEC |
| Mar 25, 2026 | Mar 27, 2026 | MED | MacKenzie Jonathan Barrett | VP, Finance & CAO | Awarded | 10,830 | 20,838 | SEC | ||
| Mar 25, 2026 | Mar 27, 2026 | MED | Maloney James P. | Chief Financial Officer | Withheld for tax | 4,624 | $9.64 | $45k | 37,675 | SEC |
| Mar 25, 2026 | Mar 27, 2026 | MED | Maloney James P. | Chief Financial Officer | Awarded | 35,358 | 73,033 | SEC | ||
| Mar 25, 2026 | Mar 27, 2026 | MED | Chard Daniel R | Chairman & CEO | Withheld for tax | 29,808 | $9.64 | $287k | 146,438 | SEC |
| Mar 25, 2026 | Mar 27, 2026 | MED | Chard Daniel R | Chairman & CEO | Awarded | 41,795 | 188,233 | SEC | ||
| Mar 20, 2026 | Mar 27, 2026 | MED | Chard Daniel R | Chairman & CEO | Bought | 17,678 | $10.11 | $179k | 17,678 | SEC |
| Jun 25, 2025 | Jun 26, 2025 | MED | Xian Ming | Director | AwardedRestricted Stock Units (cash settled) | 17,181 | $4.69 | $81k | 32,143 | SEC |
| Jun 25, 2025 | Jun 26, 2025 | MED | Schlackman Scott | Director | Awarded | 11,168 | 25,549 | SEC | ||
| Jun 25, 2025 | Jun 26, 2025 | MED | Thomas Andrea B | Director | Awarded | 11,168 | 24,017 | SEC | ||
| Jun 25, 2025 | Jun 26, 2025 | MED | Hoer Michael A. | Director | Awarded | 11,168 | 26,139 | SEC | ||
| Jun 25, 2025 | Jun 26, 2025 | MED | Geary Elizabeth A. | Director | Awarded | 11,168 | 19,545 | SEC | ||
| Jun 25, 2025 | Jun 26, 2025 | MED | Brown Jeffrey J | Director | Awarded | 20,617 | $6.14 | $127k | 38,578 | SEC |
| Jun 13, 2025 | Jun 17, 2025 | MED | Chard Daniel R | Chairman & CEO | Bought | 381 | $13.13 | $5k | 149,698 | SEC |
| Mar 25, 2025 | Mar 27, 2025 | MED | Maloney James P. | Chief Financial Officer | Awarded | 24,161 | 42,299 | SEC | ||
| Mar 25, 2025 | Mar 27, 2025 | MED | MacKenzie Jonathan Barrett | VP, Finance & CAO | Awarded | 7,671 | 11,138 | SEC | ||
| Mar 25, 2025 | Mar 27, 2025 | MED | Chard Daniel R | Chairman & CEO | Awarded | 124,953 | 176,246 | SEC | ||
| Mar 17, 2025 | Mar 18, 2025 | MED | MacKenzie Jonathan Barrett | VP, Finance & CAO | Withheld for tax | 439 | $13.99 | $6k | 3,467 | SEC |
| Mar 17, 2025 | Mar 18, 2025 | MED | Maloney James P. | Chief Financial Officer | Withheld for tax | 1,396 | $14.03 | $20k | 18,138 | SEC |
| Mar 17, 2025 | Mar 18, 2025 | MED | Chard Daniel R | Chairman & CEO | Withheld for tax | 7,809 | $13.99 | $109k | 51,293 | SEC |
| Dec 3, 2024 | Feb 11, 2025 | MED | Chard Daniel R | Chairman & CEO | Gift | 597,269 | 149,317 | SEC | ||
| Sep 13, 2024 | Sep 17, 2024 | MED | MacKenzie Jonathan Barrett | VP, Finance & CAO | Withheld for tax | 11 | $18.90 | $208 | 3,906 | SEC |
| Jun 20, 2024 | Jun 24, 2024 | MED | Brown Jeffrey J | Director | Awarded | 12,177 | $10.39 | $126k | 17,961 | SEC |
| Jun 20, 2024 | Jun 24, 2024 | MED | Thomas Andrea B | Director | Awarded | 6,596 | 12,849 | SEC | ||
| Jun 20, 2024 | Jun 24, 2024 | MED | Geary Elizabeth A. | Director | Awarded | 6,596 | 8,377 | SEC | ||
| Jun 20, 2024 | Jun 24, 2024 | MED | Hoer Michael A. | Director | Awarded | 6,596 | 14,971 | SEC | ||
| Jun 20, 2024 | Jun 24, 2024 | MED | Schlackman Scott | Director | Awarded | 6,596 | 14,381 | SEC | ||
| Jun 20, 2024 | Jun 24, 2024 | MED | Xian Ming | Director | AwardedRestricted Stock Units (cash settled) | 10,149 | 14,962 | SEC | ||
| Mar 15, 2024 | Mar 19, 2024 | MED | Maloney James P. | Chief Financial Officer | Withheld for tax | 616 | $36.61 | $23k | 19,534 | SEC |
| Mar 15, 2024 | Mar 19, 2024 | MED | MacKenzie Jonathan Barrett | VP, Finance & CAO | Withheld for tax | 134 | $36.61 | $5k | 3,917 | SEC |
| Mar 15, 2024 | Mar 19, 2024 | MED | Chard Daniel R | Chairman & CEO | Withheld for tax | 3,409 | $36.61 | $125k | 99,821 | SEC |
| Mar 13, 2024 | Mar 15, 2024 | MED | Maloney James P. | Chief Financial Officer | Awarded | 8,718 | 20,150 | SEC | ||
| Mar 13, 2024 | Mar 15, 2024 | MED | MacKenzie Jonathan Barrett | VP, Finance & CAO | Awarded | 2,565 | 4,051 | SEC | ||
| Mar 13, 2024 | Mar 15, 2024 | MED | Chard Daniel R | Chairman & CEO | Awarded | 45,087 | 103,230 | SEC | ||
| Mar 8, 2024 | Mar 12, 2024 | MED | Schlackman Scott | Director | Sold | 4,053 | $39.44 | $160k | 7,785 | SEC |
| Mar 8, 2024 | Mar 12, 2024 | MED | Schlackman Scott | Director | Exercised or settledStock Option (Right to Buy) | 1,300 | 0 | SEC |
Sales, notices and lockups (101)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Sep 30, 2026 | Chard Daniel R | MED | Director | Form 4 sale | 19,089 | $226k | 12.8% | Routine | SEC |
| Sep 29, 2026 | Sep 29, 2026 | Chard Daniel R | MED | Director | Form 144 notice | 9,544 | $112k | Notice | SEC | |
| Sep 28, 2026 | Sep 28, 2026 | Chard Daniel R | MED | Director | Form 144 notice | 9,545 | $114k | Notice | SEC | |
| Mar 8, 2024 | Mar 12, 2024 | Schlackman Scott | MED | Director | Form 4 sale | 4,053 | $160k | 34.2% | Unusual | SEC |
| Mar 8, 2024 | Mar 8, 2024 | Schlackman Scott | MED | Director | Form 144 notice | 4,053 | $160k | Notice | SEC | |
| Oct 6, 2023 | Oct 30, 2023 | Hallquist Constance J. | MED | Other | Form 4 sale | 5,613 | $415k | 72.3% | Unusual | SEC |
| Aug 15, 2023 | Aug 16, 2023 | Brown Jeffrey J | MED | Director | Form 4 sale | 38,316 | $3.5M | 100.0% | Unusual | SEC |
| Aug 14, 2023 | Aug 14, 2023 | Brown Jeffrey J | MED | Director | Form 144 notice | 38,316 | $3.6M | Notice | SEC | |
| Mar 10, 2023 | Mar 14, 2023 | Schlackman Scott | MED | Director | Form 4 sale | 2,200 | $239k | 23.2% | Plan not stated | SEC |
| Mar 10, 2022 | Mar 14, 2022 | Thomas Andrea B | MED | Director | Form 4 sale | 1,150 | $200k | 41.2% | Unusual | SEC |
| Aug 20, 2021 | Aug 24, 2021 | Byrnes Kevin G | MED | Director | Form 4 sale | 673 | $149k | 7.6% | Plan not stated | SEC |
| Jul 2, 2021 | Jul 7, 2021 | Hallquist Constance J. | MED | Director | Form 4 sale | 542 | $155k | 7.8% | Plan not stated | SEC |
| Jun 17, 2021 | Jun 21, 2021 | Chard Daniel R | MED | Chairman & CEO | Form 4 sale | 6,365 | $1.7M | 5.6% | Plan not stated | SEC |
| Jun 16, 2021 | Jun 17, 2021 | Chard Daniel R | MED | Chairman & CEO | Form 4 sale | 13,520 | $3.8M | 10.7% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 15, 2021 | Chard Daniel R | MED | Chairman & CEO | Form 4 sale | 15,115 | $4.3M | 10.7% | Plan not stated | SEC |
| May 19, 2021 | May 21, 2021 | Schlackman Scott | MED | Director | Form 4 sale | 1,000 | $310k | 16.3% | Plan not stated | SEC |
| Mar 3, 2021 | Mar 5, 2021 | Hallquist Constance J. | MED | Director | Form 4 sale | 4,500 | $1.2M | 41.6% | Unusual | SEC |
| Oct 1, 2020 | Oct 2, 2020 | Macdonald Michael C | MED | Director | Form 4 sale | 5,000 | $827k | 1.8% | Plan not stated | SEC |
| Jul 2, 2020 | Jul 6, 2020 | Hallquist Constance J. | MED | Director | Form 4 sale | 535 | $80k | 7.8% | Plan not stated | SEC |
| Jul 1, 2020 | Jul 6, 2020 | Macdonald Michael C | MED | Director | Form 4 sale | 5,000 | $694k | 1.8% | Plan not stated | SEC |
| Jun 4, 2020 | Jun 8, 2020 | Schlackman Scott | MED | Director | Form 4 sale | 3,119 | $335k | 41.3% | Unusual | SEC |
| May 6, 2020 | May 8, 2020 | Macdonald Michael C | MED | Director | Form 4 sale | 10,000 | $1M | 3.5% | Plan not stated | SEC |
| May 8, 2019 | May 9, 2019 | Sassano Carl E | MED | Director | Form 4 sale | 850 | $122k | 4.6% | Plan not stated | SEC |
| Mar 12, 2019 | Mar 13, 2019 | Sassano Carl E | MED | Director | Form 4 sale | 5,000 | $677k | 27.5% | Unusual | SEC |
| Mar 8, 2019 | Mar 12, 2019 | Schlackman Scott | MED | Director | Form 4 sale | 2,000 | $262k | 24.8% | Plan not stated | SEC |
| Mar 5, 2019 | Mar 7, 2019 | Macdonald Michael C | MED | Director | Form 4 sale | 18,825 | $2.5M | 100.0% | Unusual | SEC |
| Mar 5, 2019 | Mar 7, 2019 | Schlackman Scott | MED | Director | Form 4 sale | 2,500 | $325k | 23.7% | Plan not stated | SEC |
| Dec 3, 2018 | Dec 6, 2018 | Hallquist Constance J. | MED | Director | Form 4 sale | 1,343 | $207k | 22.3% | Plan not stated | SEC |
| Nov 9, 2018 | Nov 13, 2018 | Hallquist Constance J. | MED | Director | Form 4 sale | 1,343 | $215k | 18.2% | Plan not stated | SEC |
| Mar 20, 2018 | Mar 22, 2018 | Connolly Charles P | MED | Director | Form 4 sale | 8,000 | $728k | 16.2% | Plan not stated | SEC |
| Mar 15, 2018 | Mar 19, 2018 | Connolly Charles P | MED | Director | Form 4 sale | 7,500 | $670k | 15.7% | Plan not stated | SEC |
| Mar 9, 2018 | Mar 13, 2018 | Macdonald Michael C | MED | Director | Form 4 sale | 40,000 | $3.5M | 11.3% | Plan not stated | SEC |
| Dec 1, 2017 | Dec 5, 2017 | Welling Glenn W. | MED | Director | Form 4 sale | 275,000 | $17.8M | 92.5% | Unusual | SEC |
| Nov 13, 2017 | Nov 15, 2017 | Welling Glenn W. | MED | Director | Form 4 sale | 250,000 | $16.3M | 84.6% | Unusual | SEC |
| May 31, 2016 | Jun 1, 2016 | Visium Balanced Master Fund, Ltd. | MED | 10% owner | Form 4 sale | 1.4M | $40.8M | 100.0% | Unusual | SEC |
| Apr 1, 2016 | Apr 5, 2016 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $250k | 2.5% | Plan not stated | SEC |
| Mar 1, 2016 | Mar 3, 2016 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $255k | 2.4% | Plan not stated | SEC |
| Feb 1, 2016 | Feb 3, 2016 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $239k | 2.4% | Plan not stated | SEC |
| Jan 4, 2016 | Jan 6, 2016 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $239k | 2.4% | Plan not stated | SEC |
| Dec 1, 2015 | Dec 3, 2015 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $249k | 2.3% | Plan not stated | SEC |
| Nov 2, 2015 | Nov 4, 2015 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $239k | 2.3% | Plan not stated | SEC |
| Oct 5, 2015 | Oct 7, 2015 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $241k | 2.2% | Plan not stated | SEC |
| Sep 3, 2015 | Sep 8, 2015 | Sheetz Margaret | MED | President & COO | Form 4 sale | 6,864 | $192k | 1.8% | Plan not stated | SEC |
| Sep 2, 2015 | Sep 4, 2015 | Sheetz Margaret | MED | President & COO | Form 4 sale | 1,469 | $41k | 0.4% | Plan not stated | SEC |
| Aug 3, 2015 | Aug 5, 2015 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $256k | 2.1% | Plan not stated | SEC |
| Jul 1, 2015 | Jul 6, 2015 | Sheetz Margaret | MED | President & COO | Form 4 sale | 8,333 | $271k | 2.1% | Plan not stated | SEC |
| Jun 25, 2015 | Jun 29, 2015 | ModusLink Securities Corp | MED | 10% owner | Form 4 sale | 29,654 | $979k | 2.4% | Plan not stated | SEC |
| Jun 23, 2015 | Jun 24, 2015 | ModusLink Global Solutions Inc | MED | 10% owner | Form 4 sale | 27,443 | $906k | 2.2% | Plan not stated | SEC |
| Jun 22, 2015 | Jun 23, 2015 | ModusLink Global Solutions Inc | MED | 10% owner | Form 4 sale | 9,494 | $313k | 0.8% | Plan not stated | SEC |
| Jun 11, 2015 | Jun 15, 2015 | Bondroff Barry B | MED | Director | Form 4 sale | 1,666 | $53k | 10.3% | Plan not stated | SEC |